Bret Jensen

|RSS

Currently the editor of "The Biotech Forum," Bret Jensen was chief investment strategist for Simplified Asset Management (S.A.M.), a small long/short hedge fund based in Miami, from 2008-2011. The fund was in the top 5% of long/short hedge funds for total return in its first full year (2009), as ranked by Hedgeco fund database (more than 450 funds in category). Prior to this, he spent a decade as technology director of a Fortune 100 firm.Expand

Jensen has been a top-5%-ranked financial analyst and blogger since 2013, according to TipRanks. He holds a Bachelor of Science degree in finance from Arizona State University.

Follow Bret on Twitter: @Bret_Jensen.Collapse

RMPIA
By

Bret Jensen

 | Jun 20, 2018 | 1:00 PM EDT
It's every investor's dream to find a stock that goes up at least 1,000%; here are a few that did.
By

Bret Jensen

 | Jun 18, 2018 | 10:17 AM EDT
Leading up to potential FDA approvals can be particularly 'dicey' times for biotech investors.
By

Bret Jensen

 | Jun 15, 2018 | 4:05 PM EDT
"Economics is extremely useful as a form of employment for economists." -- John Kenneth Galbraith As always it has been good sitting…
RMPIA
By

Bret Jensen

 | Jun 15, 2018 | 2:24 PM EDT
"Despite a voluminous and often fervent literature on "income distribution," the cold fact is that most income is not distributed: It is…
By

Bret Jensen

 | Jun 15, 2018 | 12:35 PM EDT
Markets continue to be down across the board as we approach mid-day. Financials are taking it on the chin as trade tensions escalate with China. The…
By

Bret Jensen

 | Jun 15, 2018 | 10:49 AM EDT
The market is down across the board as one might expect given escalating trade tensions today. However, losses are slight in this context in the first…
By

Bret Jensen

 | Jun 15, 2018 | 9:09 AM EDT
"People of the same trade seldom meet together, even for merriment and diversion, but the conversation ends in a conspiracy against the public, or…
By

Bret Jensen

 | Jun 15, 2018 | 7:16 AM EDT
It is good to be standing in for Doug Kass here on the Daily Diary on this Friday. Hopefully we can end the trading week on an up note. Markets have…
By

Bret Jensen

 | Jun 13, 2018 | 10:00 AM EDT
Eli Lilly, AstraZeneca and vTv Therapeutics show why it's best to stay away from biotech's black hole.
By

Bret Jensen

 | Jun 12, 2018 | 4:15 PM EDT
"I love New York, even though it isn't mine, the way something has to be, a tree or a street or a house, something, anyway, that belongs to me…

BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.